Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
2
×
crispr
deals
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
multiple myeloma
national
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adalimumab (humira)
aducanumab
aduro biotech
What
bio
roundup
2
×
acquisitions
announced
approval
biogen’s
biopharmaceutical
ceo
collabs
companies
convo
covid
daniel
deal
drug
earlier
failures
gilead
gilead’s
help
introduce
ipo
littered
medicines
month
nash
new
news
o’day
plans
price
remains
road
sciences
strategy
talk
transformative
years
Language
unset
Current search:
roundup
×
novartis
×
" clinical trials "
×
startups
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More